India Warns Pharma Firms Against Indirect Promotion Of GLP-1 Weight-Loss Drugs
GLP-1 receptor agonists have gained global attention for their weight-loss benefits. In India, the segment currently has two multinational players – Novo Nordisk and Eli Lilly.